Application of schisandra chinensis polysaccharide in preparation of medicine for relieving mouse ulcerative colitis induced by DSS

The invention discloses application of schisandra chinensis polysaccharide in preparation of a medicine for relieving mouse ulcerative colitis induced by DSS. The invention provides new application of schisandra chinensis polysaccharide, SCP can relieve colitis by improving the abundance of intestin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZHANG CHENG, WEI CHUNLAI, WU CAIHONG, ZHANG BIN, LIU PENG, DAI QIAN, YUAN CHENG, LI LEKANG, TAN JU, ZHANG WANRONG, SUN JIANFENG, LU HUI, SUN YUDI, YANG YANG, CHEN XIAOLAN, LIU LI
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention discloses application of schisandra chinensis polysaccharide in preparation of a medicine for relieving mouse ulcerative colitis induced by DSS. The invention provides new application of schisandra chinensis polysaccharide, SCP can relieve colitis by improving the abundance of intestinal microbiota and inhibiting a TLR4/p65 pathway, and SCP can relieve colitis by improving the abundance of intestinal microbiota and inhibiting the TLR4/p65 pathway. 本发明公开了五味子多糖在制备缓解DSS诱导的小鼠溃疡性结肠炎的药物中的用途。本发明提供了五味子多糖的新用途，SCP可以通过改善肠道微生物群的丰度和抑制TLR4/p65途径来缓解结肠炎，SCP通过改善肠道微生物群的丰度和抑制TLR4/p65途径来缓解结肠炎。